Hematology/oncology and Stem Cell Therapy
Overview
Hematology/oncology and Stem Cell Therapy is a scientific journal, published since 2008 in English. The journal's country of origin is India and its primary focus areas are oncology and hematology.
Details
Details
Abbr.
Hematol Oncol Stem Cell Ther
Start
2008
End
Continuing
Frequency
Quarterly
p-ISSN
1658-3876
e-ISSN
2589-0646
Country
India
Language
English
Specialties
Oncology
Hematology
Hematology
Metrics
Metrics
h-index / Ranks: 10441
30
SJR / Ranks: 7501
601
CiteScore / Ranks: 5824
4.50
Recent Articles
1.
Haroon A, Mohammed Saleh M, Alahmari A, Osman S, Alotaibi A, Alzahrani H, et al.
Hematol Oncol Stem Cell Ther
. 2025 Jan;
17(4):245-247.
PMID: 39829100
Acquired factor XIII (FXIII) deficiency is a rare disorder that could be associated with autoimmune and malignant disorders with a high risk of bleeding. In acute leukemias, acquired FXIII deficiency...
2.
Lopez A, Cordero R, Luque G, Calle R, Hawkins M, Martinez L, et al.
Hematol Oncol Stem Cell Ther
. 2025 Jan;
17(4):239-244.
PMID: 39829099
Background And Objectives: The immature platelet fraction (IPF) count is a parameter that quantifies young and reticulated platelets in peripheral blood, which reflects platelet production in the bone marrow. It...
3.
Baddourah R, Baddourah D, Alsweedan D, Al Sheyyab M, Nimri O, Alsweedan S
Hematol Oncol Stem Cell Ther
. 2025 Jan;
17(4):233-238.
PMID: 39829098
Background And Objectives: The most recent study on pediatric cancer epidemiology in Jordan was published in 2003. This study aims to provide updated epidemiological data for local clinicians, policymakers, and...
4.
AlAbdullah H, Alanzi F, Alhuthil R, Alshaibani T, AlBeeshi N, Alqahtani A, et al.
Hematol Oncol Stem Cell Ther
. 2025 Jan;
17(4):227-232.
PMID: 39829097
Background: Patients who underwent hematopoietic stem cell transplantation (HSCT) are considered at high risk for pediatric intensive care unit (PICU) admission. Therefore, this study aimed to assess outcomes and mortality-related...
5.
Moiseev I, Cherkashina A, Rudakova T, Volkov N, Zhogolev D, Durova S, et al.
Hematol Oncol Stem Cell Ther
. 2025 Jan;
17(4):219-226.
PMID: 39829096
The outcomes of haploidentical hematopoietic cell transplantation (haplo-HCT) have improved with the implication of new in vivo and ex vivo graft-versus-host disease (GVHD) prophylaxis regimens. However, primary graft failure is...
6.
Koc O, Dogan O, Sahin U, Kircali E, Koyun D, Arat M, et al.
Hematol Oncol Stem Cell Ther
. 2025 Jan;
17(4):211-218.
PMID: 39829095
Despite numerous reports on the procoagulant activities of G-CSF, the effect of plerixafor on the hemostatic system is not clearly understood. This study aims to evaluate the effects of plerixafor...
7.
Valsami S, Dryllis G, Papanastasi K, Kokoris S, Kriebardis A, Nikitiadis K, et al.
Hematol Oncol Stem Cell Ther
. 2025 Jan;
17(4):203-210.
PMID: 39829094
Transfusion of blood products is a common lifesaving medical procedure in clinical practice. However, it poses the risk of potential adverse reactions for the recipient. Transfusion-associated graft-versus-host-disease (TA-GVHD) is a...
8.
Sharma A, Sharma A, Soubani A
Hematol Oncol Stem Cell Ther
. 2024 Oct;
17(3):200-202.
PMID: 39412756
No abstract available.
9.
Greinix H, Iftikhar R, Chaudhry Q, Ahmed P, Al-Khabori M, Gaziev J, et al.
Hematol Oncol Stem Cell Ther
. 2024 Oct;
17(3):190-199.
PMID: 39412755
The eighth workshop of the Worldwide Network for Blood and Marrow Transplantation (WBMT) was held in Islamabad, Pakistan, from September 22 to 23, 2022, aiming to foster hematopoietic stem cell...
10.
Ibrahim M, Khodeary A, Aziz S, Mahmoud M, Abdel-Baset A, Mohamed T, et al.
Hematol Oncol Stem Cell Ther
. 2024 Oct;
17(3):184-189.
PMID: 39412754
Background And Objectives: Aplastic anemia (AA) is a disease caused by bone marrow (BM) failure. There are many similarities between AA and hypoplastic myelodysplastic syndrome (MDS); hence, differentiating them could...